Rep. Ed Towns: J&J uncooperative in federal probe
NEW YORK Johnson & Johnson has been less than cooperative with a congressional probe into the recent product recalls of J&J’s McNeil Consumer Healthcare division and the subsequent shuttering of its Fort Washington, Pa., manufacturing facility, the New York Times reported Thursday.
In an interview with the Times, Rep. Ed Towns, D-N.Y., suggested J&J has been less cooperative in responding to requests than were either Bank of America or the insurance giant A.I.G. when they recently were under investigation.
Towns and the committee may have to resort to subpoenas to compel J&J’s cooperation, Towns said.
Bonnie Jacobs, McNeil spokeswoman, countered that the company has already produced approximately 20,000 pages of documents, and that corporate executives were made available for interviews in a timely fashion, the Times reported.
Bayer saluted for blood-glucose meter design
TARRYTOWN, N.Y. Bayer on Wednesday received a silver Medical Design Excellence Award for its Countour USB meter, the company announced. The MDEA recognizes excellence in medical product design and manufacturing.
"Winning a Medical Design Excellence Award is quite an honor," stated Rick Kates, Bayer global senior director, digital health. "We’re gratified that the innovation and hard work that went into bringing this product to life has been so richly recognized.”
With the Countour USB meter, up to 2,000 stored blood glucose measurements can be transferred wirelessly. The blood-glucose measurements are displayed in graph or table form using an integrated diabetes management software that provides diabetes patients and healthcare professionals with access to blood sugar data and trends to help optimize diabetes management.
Lansinoh makes donation to InfantRisk Center
ALEXANDRIA, Va. Lansinoh has made a donation to a center that will provide pregnant and breast-feeding women and their healthcare providers with accurate information and evidence-based counsel on medications that are safe to use and alternatives to drug-based treatments.
The $20,000 donation to InfantRisk Center at Texas Tech University in Amarillo, Texas, will provide mothers and mothers-to-be with information about specific prescription and over-the-counter medications, and will help further drive research on the effects of medications on pregnancies, breast-fed infants and their mothers, and, ultimately, will enhance babies’ health, Lansinoh said.
“It’s great that a resource like this will finally be available in the United States,” said Gina Ciagne, director of breast-feeding and consumer relations at Lansinoh. “The InfantRisk Center is going to be an excellent resource to help clear up any confusion and misinformation regarding medications and whether or not they are safe to use during pregnancy and lactation. Very often, moms are urged to stop breast-feeding because of a perceived conflict with a medication, but that is not always necessary. If the incidence of premature weaning from breast-feeding can be reduced because of information and support that the Center will provide, that will be a great victory.”